As representatives of the new economy and new kinetic energy, fast-growing innovative companies such as unicorn companies are important indicators for measuring regional innovation capabilities and innovation and entrepreneurship ecology. While doing its best to foster the development of innovative companies such as unicorn companies, Shanghai has also innovatively released a list of "potential unicorns" to meet the individual demands of companies and create a good atmosphere and business environment. Founded 7 years ago, this innovative medical device company focuses on the treatment of neurovascular diseases and has obtained more than 350 global patents. The company independently developed the "coil" for the treatment of ruptured cerebral vascular aneurysms. It is the first neuroembolization product in China that has obtained the certification of relevant medical devices in the United States, Europe and Japan.